Amanote Research

Amanote Research

    RegisterSign In

Discover open access scientific publications

Search, annotate, share and cite publications


Publications by Adam R. Glassman

Reply

Ophthalmology
Ophthalmology
2017English

Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment

Ophthalmology
Ophthalmology
2012English

Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment: 5-Year Randomized Trial Results

Ophthalmology
Ophthalmology
2015English

Expanded 2-Year Follow-Up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

Ophthalmology
Ophthalmology
2011English

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

Ophthalmology
Ophthalmology
2016English

Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy

JAMA Ophthalmology
Ophthalmology
2017English

Comparative Effectiveness Trial for Diabetic Macular Edema

JAMA Ophthalmology
Ophthalmology
2015English

Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema

American Journal of Ophthalmology
Ophthalmology
2016English

Green or Yellow Laser Treatment for Diabetic Macular Edema

Retina
MedicineOphthalmology
2013English

The Risk of Endophthalmitis Following Intravitreal Triamcinolone Injection in the DRCRnet and SCORE Clinical Trials

American Journal of Ophthalmology
Ophthalmology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy